Compare FUL & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FUL | BHC |
|---|---|---|
| Founded | 1887 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.5B |
| IPO Year | 2007 | 1996 |
| Metric | FUL | BHC |
|---|---|---|
| Price | $60.67 | $5.37 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $68.40 | $8.33 |
| AVG Volume (30 Days) | 708.2K | ★ 1.5M |
| Earning Date | 03-25-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.55% | N/A |
| EPS Growth | 19.57 | ★ 423.08 |
| EPS | 0.38 | ★ 0.42 |
| Revenue | $2,897,000,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $4.96 | $4.48 |
| Revenue Next Year | $4.00 | N/A |
| P/E Ratio | $159.45 | ★ $12.77 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $47.56 | $4.28 |
| 52 Week High | $68.63 | $8.69 |
| Indicator | FUL | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.30 | 49.11 |
| Support Level | $57.24 | $4.93 |
| Resistance Level | $60.57 | $7.22 |
| Average True Range (ATR) | 2.26 | 0.18 |
| MACD | 1.19 | 0.08 |
| Stochastic Oscillator | 79.78 | 60.87 |
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.